Show simple item record

dc.contributor.authorGoldstein, D
dc.contributor.authorLemech, C
dc.contributor.authorValle, Juan W
dc.date.accessioned2017-09-22T15:44:04Z
dc.date.available2017-09-22T15:44:04Z
dc.date.issued2017
dc.identifier.citationNew molecular and immunotherapeutic approaches in biliary cancer. 2017, 2 (Suppl 1):e000152 ESMO Openen
dc.identifier.issn2059-7029
dc.identifier.pmid28848675
dc.identifier.doi10.1136/esmoopen-2016-000152
dc.identifier.urihttp://hdl.handle.net/10541/620575
dc.description.abstractBiliary tract carcinoma is a collective term for a group of rare gastrointestinal cancers. This overview outlines the key pathways and specialised therapeutics in biliary cancer and the emerging role of immunotherapy by highlighting the rationale and selected examples of studies in each area.
dc.language.isoenen
dc.rightsArchived with thanks to ESMO openen
dc.titleNew molecular and immunotherapeutic approaches in biliary cancer.en
dc.typeArticleen
dc.contributor.departmentDepartment of Medical Oncology at the Nelune Cancer Centre, Prince of Wales Hospital, Sydney, New South Walesen
dc.identifier.journalESMO Openen
refterms.dateFOA2018-12-17T15:03:31Z
html.description.abstractBiliary tract carcinoma is a collective term for a group of rare gastrointestinal cancers. This overview outlines the key pathways and specialised therapeutics in biliary cancer and the emerging role of immunotherapy by highlighting the rationale and selected examples of studies in each area.


Files in this item

Thumbnail
Name:
e000152.full.pdf
Size:
564.9Kb
Format:
PDF
Description:
Full text open access article

This item appears in the following Collection(s)

Show simple item record